US Stock MarketDetailed Quotes

FNCH Finch Therapeutics

Watchlist
  • 12.000
  • +0.144+1.21%
15min DelayClose Nov 27 16:00 ET
19.27MMarket Cap-1363P/E (TTM)

Finch Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
48.39%-4.73M
67.40%-4.36M
57.91%-31.51M
74.03%-3.71M
72.45%-5.26M
42.19%-9.16M
47.82%-13.38M
-11.50%-74.85M
-3.52%-14.27M
-33.07%-19.09M
Net income from continuing operations
30.45%-4.83M
93.78%-3.88M
34.80%-74.75M
88.74%-3.04M
94.02%-2.42M
69.38%-6.95M
-153.78%-62.35M
-97.12%-114.65M
-41.74%-27.01M
-305.53%-40.37M
Operating gains losses
----
----
10,314.29%729K
-4,300.00%-42K
--22K
---797K
--1.55M
100.38%7K
--1K
--0
Depreciation and amortization
-22.81%44K
-96.85%43K
-72.40%1.52M
-96.88%44K
-96.30%52K
-95.82%57K
2.70%1.37M
139.33%5.51M
107.67%1.41M
120.22%1.41M
Deferred tax
--0
--0
---3.46M
--0
--0
--0
---3.46M
--0
--0
--0
Other non cash items
181.46%577K
-42.36%566K
-36.68%1.91M
-99.51%5K
-28.10%719K
-73.06%205K
305.79%982K
230.56%3.02M
324.69%1.02M
327.35%1M
Change In working capital
73.23%-528K
-185.66%-1.12M
-246.55%-5.42M
-149.34%-786K
-208.94%-3.97M
-167.98%-1.97M
127.47%1.31M
89.22%-1.56M
-45.91%1.59M
81.04%-1.29M
-Change in receivables
--0
--0
-59.14%143K
99.31%-1K
--0
5,450.00%107K
-88.51%37K
-41.76%350K
-107.56%-144K
216.78%174K
-Change in prepaid assets
-162.15%-831K
-74.96%310K
183.87%2.12M
-105.52%-108K
249.73%1.31M
-115.01%-317K
117.76%1.24M
21.39%-2.53M
148.78%1.96M
-81.75%374K
-Change in payables and accrued expense
291.07%877K
69.80%-870K
-334.47%-8.79M
-611.76%-435K
-703.61%-5.01M
90.28%-459K
-261.31%-2.88M
-127.21%-2.02M
-98.63%85K
-65.16%830K
-Change in other current assets
--0
--0
514.79%4.03M
--0
--0
--0
1,011.02%4.03M
113.99%656K
--0
--348K
-Change in other current liabilities
55.95%-574K
49.55%-563K
-248.01%-2.93M
20.13%-242K
91.00%-271K
-123.40%-1.3M
-308.79%-1.12M
296.92%1.98M
-13.06%-303K
-1,085.83%-3.01M
Cash from discontinued investing activities
Operating cash flow
48.39%-4.73M
67.40%-4.36M
57.91%-31.51M
74.03%-3.71M
72.45%-5.26M
42.19%-9.16M
47.82%-13.38M
-11.50%-74.85M
-3.52%-14.27M
-33.07%-19.09M
Investing cash flow
Cash flow from continuing investing activities
0
0
160.82%1.33M
200.00%51K
106.10%20K
242.06%1.27M
98.46%-14K
86.29%-2.18M
97.45%-51K
86.13%-328K
Net PPE purchase and sale
--0
--0
160.82%1.33M
200.00%51K
106.10%20K
242.06%1.27M
98.46%-14K
86.29%-2.18M
97.45%-51K
86.13%-328K
Cash from discontinued investing activities
Investing cash flow
--0
--0
160.82%1.33M
200.00%51K
106.10%20K
242.06%1.27M
98.46%-14K
86.29%-2.18M
97.45%-51K
86.13%-328K
Financing cash flow
Cash flow from continuing financing activities
0
0
-208.62%-16.16M
0
0
-99.97%4K
-323,280.00%-16.16M
-87.51%14.87M
-25.71%52K
-8.89%41K
Net issuance payments of debt
--0
--0
-209.78%-16.16M
-14,337.50%-1.16M
--0
--0
-166,566.67%-15M
54,603.70%14.72M
-300.00%-8K
25.00%-3K
Proceeds from stock option exercised by employees
----
----
--0
--0
----
----
----
-91.02%289K
-15.49%60K
-10.20%44K
Net other financing activities
----
----
----
----
--0
--4K
---1.16M
95.04%-132K
--0
--0
Cash from discontinued financing activities
Financing cash flow
--0
--0
-208.62%-16.16M
--0
--0
-99.97%4K
-323,280.00%-16.16M
-87.51%14.87M
-25.71%52K
-8.89%41K
Net cash flow
Beginning cash position
-47.78%23.11M
-62.78%27.47M
-45.72%73.81M
-64.66%31.13M
-66.15%36.37M
-59.56%44.25M
-45.72%73.81M
36.09%135.97M
-41.93%88.08M
-36.17%107.46M
Current changes in cash
40.04%-4.73M
85.24%-4.36M
25.46%-46.33M
74.39%-3.66M
72.95%-5.24M
-302.55%-7.88M
-11.31%-29.55M
-272.40%-62.16M
9.21%-14.27M
-16.28%-19.38M
End cash Position
-49.45%18.38M
-47.78%23.11M
-62.78%27.47M
-62.78%27.47M
-64.66%31.13M
-66.15%36.37M
-59.56%44.25M
-45.72%73.81M
-45.72%73.81M
-41.93%88.08M
Free cash flow
48.39%-4.73M
67.44%-4.36M
59.10%-31.51M
74.22%-3.69M
72.91%-5.26M
45.28%-9.16M
49.56%-13.4M
7.32%-77.03M
9.28%-14.32M
-16.21%-19.42M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 48.39%-4.73M67.40%-4.36M57.91%-31.51M74.03%-3.71M72.45%-5.26M42.19%-9.16M47.82%-13.38M-11.50%-74.85M-3.52%-14.27M-33.07%-19.09M
Net income from continuing operations 30.45%-4.83M93.78%-3.88M34.80%-74.75M88.74%-3.04M94.02%-2.42M69.38%-6.95M-153.78%-62.35M-97.12%-114.65M-41.74%-27.01M-305.53%-40.37M
Operating gains losses --------10,314.29%729K-4,300.00%-42K--22K---797K--1.55M100.38%7K--1K--0
Depreciation and amortization -22.81%44K-96.85%43K-72.40%1.52M-96.88%44K-96.30%52K-95.82%57K2.70%1.37M139.33%5.51M107.67%1.41M120.22%1.41M
Deferred tax --0--0---3.46M--0--0--0---3.46M--0--0--0
Other non cash items 181.46%577K-42.36%566K-36.68%1.91M-99.51%5K-28.10%719K-73.06%205K305.79%982K230.56%3.02M324.69%1.02M327.35%1M
Change In working capital 73.23%-528K-185.66%-1.12M-246.55%-5.42M-149.34%-786K-208.94%-3.97M-167.98%-1.97M127.47%1.31M89.22%-1.56M-45.91%1.59M81.04%-1.29M
-Change in receivables --0--0-59.14%143K99.31%-1K--05,450.00%107K-88.51%37K-41.76%350K-107.56%-144K216.78%174K
-Change in prepaid assets -162.15%-831K-74.96%310K183.87%2.12M-105.52%-108K249.73%1.31M-115.01%-317K117.76%1.24M21.39%-2.53M148.78%1.96M-81.75%374K
-Change in payables and accrued expense 291.07%877K69.80%-870K-334.47%-8.79M-611.76%-435K-703.61%-5.01M90.28%-459K-261.31%-2.88M-127.21%-2.02M-98.63%85K-65.16%830K
-Change in other current assets --0--0514.79%4.03M--0--0--01,011.02%4.03M113.99%656K--0--348K
-Change in other current liabilities 55.95%-574K49.55%-563K-248.01%-2.93M20.13%-242K91.00%-271K-123.40%-1.3M-308.79%-1.12M296.92%1.98M-13.06%-303K-1,085.83%-3.01M
Cash from discontinued investing activities
Operating cash flow 48.39%-4.73M67.40%-4.36M57.91%-31.51M74.03%-3.71M72.45%-5.26M42.19%-9.16M47.82%-13.38M-11.50%-74.85M-3.52%-14.27M-33.07%-19.09M
Investing cash flow
Cash flow from continuing investing activities 00160.82%1.33M200.00%51K106.10%20K242.06%1.27M98.46%-14K86.29%-2.18M97.45%-51K86.13%-328K
Net PPE purchase and sale --0--0160.82%1.33M200.00%51K106.10%20K242.06%1.27M98.46%-14K86.29%-2.18M97.45%-51K86.13%-328K
Cash from discontinued investing activities
Investing cash flow --0--0160.82%1.33M200.00%51K106.10%20K242.06%1.27M98.46%-14K86.29%-2.18M97.45%-51K86.13%-328K
Financing cash flow
Cash flow from continuing financing activities 00-208.62%-16.16M00-99.97%4K-323,280.00%-16.16M-87.51%14.87M-25.71%52K-8.89%41K
Net issuance payments of debt --0--0-209.78%-16.16M-14,337.50%-1.16M--0--0-166,566.67%-15M54,603.70%14.72M-300.00%-8K25.00%-3K
Proceeds from stock option exercised by employees ----------0--0-------------91.02%289K-15.49%60K-10.20%44K
Net other financing activities ------------------0--4K---1.16M95.04%-132K--0--0
Cash from discontinued financing activities
Financing cash flow --0--0-208.62%-16.16M--0--0-99.97%4K-323,280.00%-16.16M-87.51%14.87M-25.71%52K-8.89%41K
Net cash flow
Beginning cash position -47.78%23.11M-62.78%27.47M-45.72%73.81M-64.66%31.13M-66.15%36.37M-59.56%44.25M-45.72%73.81M36.09%135.97M-41.93%88.08M-36.17%107.46M
Current changes in cash 40.04%-4.73M85.24%-4.36M25.46%-46.33M74.39%-3.66M72.95%-5.24M-302.55%-7.88M-11.31%-29.55M-272.40%-62.16M9.21%-14.27M-16.28%-19.38M
End cash Position -49.45%18.38M-47.78%23.11M-62.78%27.47M-62.78%27.47M-64.66%31.13M-66.15%36.37M-59.56%44.25M-45.72%73.81M-45.72%73.81M-41.93%88.08M
Free cash flow 48.39%-4.73M67.44%-4.36M59.10%-31.51M74.22%-3.69M72.91%-5.26M45.28%-9.16M49.56%-13.4M7.32%-77.03M9.28%-14.32M-16.21%-19.42M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data